초음파 메스 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 용도별, 최종 용도별, 지역별, 부문별 예측(2024-2030년)

Ultrasonic Scalpel Market Growth & Trends:

The global ultrasonic scalpel market size is anticipated to reach USD 3.62 billion by 2030, registering a CAGR of 7.99% from 2024 to 2030, according to a new report by Grand View Research, Inc. An increase in patient preference for minimally invasive procedures, rising awareness about the minimally invasive procedures in healthcare professionals, and rapid advancements in healthcare technology are key contributors to the ultrasonic scalpel industry's growth. The increasing number of surgeries, especially in the geriatric population, is expected to boost the market growth over the forecast period.

According to the Population Reference Bureau, the number of people in the U.S. aged 65 and above is expected to nearly double from 52 million in 2018 to 95 million by 2060. Thus, the geriatric population is expected to account for up to 50% of surgeries. Increasing life expectancy and age-associated comorbidities have resulted in the continued growth of the elderly population needing surgical care. In the U.S., the most common chronic health conditions among the elderly include arthritis, heart disease, and hypertension. For instance, as per a WHO report, published in September 2023, cardiovascular diseases account for 17.9 million deaths annually, followed by cancer, chronic lower respiratory diseases, and diabetes.

Technological developments in the field of ultrasonic scalpels are expected to boost the growth opportunities in the forecast period. In July 2023, XISHA0, announced the launch of UT-C-S1 Ultrasonic Bone Scalpel which is more efficient and precise for bone cutting. Moreover, in August 2022, TiSFREE's new ultrasonic scalpel from Bluesail+ has received NMPA clearance. In July 2023, Heal Force announced the launch of the Heal Force UHS100 ultrasonic scalpel system which offers surgeons unparalleled control and accuracy during procedures. Thus, the rising product launches in the field are expected to boost the market growth over the forecast period.

Ultrasonic Scalpel Market Report Highlights:

• Based on product, the ultrasonic scalpel systems segment dominated the market in 2023 with the largest share owing to the rising preference for laparoscopy procedures
• Based on application, the orthopedic surgery segment dominated the market in 2023 with the highest share as orthopedic injuries have become prevalent in the past few years
• Based on end-use, the hospitals segment held the largest share of the market in 2023 as hospitals are the go-to centers for all patients seeking major surgeries worldwide
• North America dominated the overall regional market with the highest revenue share in 2023 owing to technological advancements and the growing incidence of chronic conditions in the region

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Product
  • 1.1.2. Application
  • 1.1.3. End-use
  • 1.1.4. Regional scope
  • 1.1.5. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
    • 1.3.5.1. Data for primary interviews in North America
    • 1.3.5.2. Data for primary interviews in Europe
    • 1.3.5.3. Data for primary interviews in Asia Pacific
    • 1.3.5.4. Data for primary interviews in Latin America
    • 1.3.5.5. Data for Primary interviews in MEA
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.6.2. Volume price analysis (Model 2)
    • 1.6.2.1. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives
  • 1.9.1. Objective 1
  • 1.9.2. Objective 2

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. Application outlook
  • 2.2.3. End-use outlook
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Ultrasonic Scalpel Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Rising prevalence of chronic diseases.
    • 3.2.1.2. Increasing number of surgeries, especially in geriatric population
    • 3.2.1.3. Increasing preference for minimally invasive surgeries
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. High cost of ultrasonic scalpel systems
  • 3.2.3. Market opportunity analysis
• 3.3. Ultrasonic Scalpel Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape
  • 3.3.3. Covid-19 Impact Analysis

Chapter 4. Ultrasonic Scalpel Market: Product Estimates & Trend Analysis

• 4.1. Definitions and Scope
  • 4.1.1. Ultrasonic scalpel system
  • 4.1.2. Ultrasonic scalpel accessories
  • 4.1.3. Ultrasonic scalpel generators
• 4.2. Product Market Share, 2018 & 2030
• 4.3. Segment Dashboard
• 4.4. Global Ultrasonic Scalpel Market by Product Outlook
• 4.5. Market Size & Forecasts and Trend Analyses, 2023 to 2030 for the following
  • 4.5.1. Ultrasonic scalpel system
    • 4.5.1.1. Ultrasonic scalpel system market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5.2. Ultrasonic scalpel accessories
    • 4.5.2.1. Ultrasonic scalpel accessories market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2.2. Ultrasonic scalpel generators market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Ultrasonic Scalpel Market: Application Estimates & Trend Analysis

• 5.1. Definitions and Scope
  • 5.1.1. Orthopedic surgery
  • 5.1.2. Gynecological surgery
  • 5.1.3. Ophthalmic surgery
  • 5.1.4. Urological surgery
  • 5.1.5. Cardiovascular surgery
  • 5.1.6. Others
• 5.2. Application Market Share, 2018 & 2030
• 5.3. Segment Dashboard
• 5.4. Global Ultrasonic Scalpel Market by Application Outlook
• 5.5. Market Size & Forecasts and Trend Analyses, 2023 to 2030 for the following
  • 5.5.1. Orthopedic surgery
    • 5.5.1.1. Orthopedic surgery market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5.2. Gynecological surgery
    • 5.5.2.1. Gynecological surgery market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5.3. Ophthalmic surgery
    • 5.5.3.1. Ophthalmic surgery market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5.4. Urological surgery
    • 5.5.4.1. Urological surgery market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5.5. Cardiovascular surgery
    • 5.5.5.1. Cardiovascular surgery market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5.6. Others
    • 5.5.6.1. Others market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Ultrasonic Scalpel Devices: End-use Estimates & Trend Analysis

• 6.1. Definitions and Scope
  • 6.1.1. Hospitals
  • 6.1.2. Ambulatory surgery centers
  • 6.1.3. Specialty clinics
• 6.2. End-use Market Share, 2018 & 2030
• 6.3. Segment Dashboard
• 6.4. Global Ultrasonic Scalpel Market by End-use Outlook
• 6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.5.1. Hospitals
    • 6.5.1.1. Hospitals market estimates and forecast 2018 to 2030 (USD Million)
  • 6.5.2. Ambulatory surgery centers
    • 6.5.2.1. Ambulatory surgery centers market estimates and forecast 2018 to 2030 (USD Million)
  • 6.5.3. Specialty clinics
    • 6.5.3.1. Specialty clinics market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Ultrasonic Scalpel Market: Regional Estimates & Trend Analysis

• 7.1. Regional market share analysis, 2023 & 2030
• 7.2. Regional Market Dashboard
• 7.3. Global Regional Market Snapshot
• 7.4. Regional Market Share and Leading Players, 2023
  • 7.4.1. North America
  • 7.4.2. Europe
  • 7.4.3. Asia Pacific
  • 7.4.4. Latin America
  • 7.4.5. Middle East and Africa
• 7.5. Market Application, & Forecasts and Trend Analysis, 2018 to 2030
• 7.6. North America
  • 7.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
  • 7.6.2. U.S.
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Competitive scenario
    • 7.6.2.3. Regulatory framework
    • 7.6.2.4. Reimbursement scenario
    • 7.6.2.5. U.S. market estimates and forecasts, 2018 - 2030
  • 7.6.3. Canada
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. Competitive scenario
    • 7.6.3.3. Regulatory framework
    • 7.6.3.4. Reimbursement scenario
    • 7.6.3.5. Canada market estimates and forecasts, 2018 - 2030
• 7.7. Europe
  • 7.7.1. UK
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Competitive scenario
    • 7.7.1.3. Regulatory framework
    • 7.7.1.4. Reimbursement scenario
    • 7.7.1.5. UK market estimates and forecasts, 2018 - 2030
  • 7.7.2. Germany
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Competitive scenario
    • 7.7.2.3. Regulatory framework
    • 7.7.2.4. Reimbursement scenario
    • 7.7.2.5. Germany market estimates and forecasts, 2018 - 2030
  • 7.7.3. France
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Competitive scenario
    • 7.7.3.3. Regulatory framework
    • 7.7.3.4. Reimbursement scenario
    • 7.7.3.5. France market estimates and forecasts, 2018 - 2030
  • 7.7.4. Italy
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Competitive scenario
    • 7.7.4.3. Regulatory framework
    • 7.7.4.4. Reimbursement scenario
    • 7.7.4.5. Italy market estimates and forecasts, 2018 - 2030
  • 7.7.5. Spain
    • 7.7.5.1. Key country dynamics
    • 7.7.5.2. Competitive scenario
    • 7.7.5.3. Regulatory framework
    • 7.7.5.4. Reimbursement scenario
    • 7.7.5.5. Spain market estimates and forecasts, 2018 - 2030
  • 7.7.6. Denmark
    • 7.7.6.1. Key country dynamics
    • 7.7.6.2. Competitive scenario
    • 7.7.6.3. Regulatory framework
    • 7.7.6.4. Reimbursement scenario
    • 7.7.6.5. Denmark market estimates and forecasts, 2018 - 2030
  • 7.7.7. Sweden
    • 7.7.7.1. Key country dynamics
    • 7.7.7.2. Competitive scenario
    • 7.7.7.3. Regulatory framework
    • 7.7.7.4. Reimbursement scenario
    • 7.7.7.5. Sweden market estimates and forecasts, 2018 - 2030
  • 7.7.8. Norway
    • 7.7.8.1. Key country dynamics
    • 7.7.8.2. Competitive scenario
    • 7.7.8.3. Regulatory framework
    • 7.7.8.4. Reimbursement scenario
    • 7.7.8.5. Norway market estimates and forecasts, 2018 - 2030
• 7.8. Asia Pacific
  • 7.8.1. Japan
    • 7.8.1.1. Key country dynamics
    • 7.8.1.2. Competitive scenario
    • 7.8.1.3. Regulatory framework
    • 7.8.1.4. Reimbursement scenario
    • 7.8.1.5. Japan market estimates and forecasts, 2018 - 2030
  • 7.8.2. India
    • 7.8.2.1. Key country dynamics
    • 7.8.2.2. Competitive scenario
    • 7.8.2.3. Regulatory framework
    • 7.8.2.4. Reimbursement scenario
    • 7.8.2.5. India market estimates and forecasts, 2018 - 2030
  • 7.8.3. China
    • 7.8.3.1. Key country dynamics
    • 7.8.3.2. Competitive scenario
    • 7.8.3.3. Regulatory framework
    • 7.8.3.4. Reimbursement scenario
    • 7.8.3.5. China market estimates and forecasts, 2018 - 2030
  • 7.8.4. South Korea
    • 7.8.4.1. Key country dynamics
    • 7.8.4.2. Competitive scenario
    • 7.8.4.3. Regulatory framework
    • 7.8.4.4. Reimbursement scenario
    • 7.8.4.5. South Korea market estimates and forecasts, 2018 - 2030
  • 7.8.5. Australia
    • 7.8.5.1. Key country dynamics
    • 7.8.5.2. Competitive scenario
    • 7.8.5.3. Regulatory framework
    • 7.8.5.4. Reimbursement scenario
    • 7.8.5.5. Australia market estimates and forecasts, 2018 - 2030
  • 7.8.6. Thailand
    • 7.8.6.1. Key country dynamics
    • 7.8.6.2. Competitive scenario
    • 7.8.6.3. Regulatory framework
    • 7.8.6.4. Reimbursement scenario
    • 7.8.6.5. Thailand market estimates and forecasts, 2018 - 2030
• 7.9. Latin America
  • 7.9.1. Brazil
    • 7.9.1.1. Key country dynamics
    • 7.9.1.2. Competitive scenario
    • 7.9.1.3. Regulatory framework
    • 7.9.1.4. Reimbursement scenario
    • 7.9.1.5. Brazil market estimates and forecasts, 2018 - 2030
  • 7.9.2. Mexico
    • 7.9.2.1. Key country dynamics
    • 7.9.2.2. Competitive scenario
    • 7.9.2.3. Regulatory framework
    • 7.9.2.4. Reimbursement scenario
    • 7.9.2.5. Mexico market estimates and forecasts, 2018 - 2030
  • 7.9.3. Argentina
    • 7.9.3.1. Key country dynamics
    • 7.9.3.2. Competitive scenario
    • 7.9.3.3. Regulatory framework
    • 7.9.3.4. Reimbursement scenario
    • 7.9.3.5. Argentina market estimates and forecasts, 2018 - 2030
• 7.10. MEA
  • 7.10.1. South Africa
    • 7.10.1.1. Key country dynamics
    • 7.10.1.2. Competitive scenario
    • 7.10.1.3. Regulatory framework
    • 7.10.1.4. Reimbursement scenario
    • 7.10.1.5. South Africa market estimates and forecasts, 2018 - 2030
  • 7.10.2. Saudi Arabia
    • 7.10.2.1. Key country dynamics
    • 7.10.2.2. Competitive scenario
    • 7.10.2.3. Regulatory framework
    • 7.10.2.4. Reimbursement scenario
    • 7.10.2.5. Saudi Arabia market estimates and forecasts, 2018 - 2030
  • 7.10.3. UAE
    • 7.10.3.1. Key country dynamics
    • 7.10.3.2. Competitive scenario
    • 7.10.3.3. Regulatory framework
    • 7.10.3.4. Reimbursement scenario
    • 7.10.3.5. UAE market estimates and forecasts, 2018 - 2030
  • 7.10.4. Kuwait
    • 7.10.4.1. Key country dynamics
    • 7.10.4.2. Competitive scenario
    • 7.10.4.3. Regulatory framework
    • 7.10.4.4. Reimbursement scenario
    • 7.10.4.5. Kuwait market estimates and forecasts, 2018 - 2030

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company/Competition Categorization
  • 8.2.1. Innovators
• 8.3. Vendor Landscape
  • 8.3.1. List of key distributors and channel partners
  • 8.3.2. Key customers
  • 8.3.3. Key company market share analysis, 2023
  • 8.3.4. Surgnova
    • 8.3.4.1. Company overview
    • 8.3.4.2. Financial performance
    • 8.3.4.3. Product benchmarking
    • 8.3.4.4. Strategic initiatives
  • 8.3.5. Johnson and Johnson
    • 8.3.5.1. Company overview
    • 8.3.5.2. Financial performance
    • 8.3.5.3. Product benchmarking
    • 8.3.5.4. Strategic initiatives
  • 8.3.6. Wuhan BBT Mini-Invasive Medical Tech. Co., Ltd.
    • 8.3.6.1. Company overview
    • 8.3.6.2. Financial performance
    • 8.3.6.3. Product benchmarking
    • 8.3.6.4. Strategic initiatives
  • 8.3.7. Axon Medical Solutions
    • 8.3.7.1. Company overview
    • 8.3.7.2. Financial performance
    • 8.3.7.3. Product benchmarking
    • 8.3.7.4. Strategic initiatives
  • 8.3.8. Olympus Company overview
    • 8.3.8.1. Financial performance
    • 8.3.8.2. Product benchmarking
    • 8.3.8.3. Strategic initiatives
  • 8.3.9. Bioventus LLC
    • 8.3.9.1. Company overview
    • 8.3.9.2. Financial performance
    • 8.3.9.3. Product benchmarking
    • 8.3.9.4. Strategic initiatives
  • 8.3.10. Medtronic PLC
    • 8.3.10.1. Company overview
    • 8.3.10.2. Financial performance
    • 8.3.10.3. Product benchmarking
    • 8.3.10.4. Strategic initiatives
  • 8.3.11. BOWA Medical UK
    • 8.3.11.1. Company overview
    • 8.3.11.2. Financial performance
    • 8.3.11.3. Product benchmarking
    • 8.3.11.4. Strategic initiatives
  • 8.3.12. Reach Surgical
    • 8.3.12.1. Company overview
    • 8.3.12.2. Financial performance
    • 8.3.12.3. Product benchmarking
    • 8.3.12.4. Strategic initiatives
  • 8.3.13. Industrial Design Consultancy Ltd
    • 8.3.13.1. Company overview
    • 8.3.13.2. Financial performance
    • 8.3.13.3. Product benchmarking
    • 8.3.13.4. Strategic initiatives